Antihypertensive drugs in COVID-19 infection-Reference-Cited by-同舟云学术

Antihypertensive drugs in COVID-19 infection

Published:2020-06-05 Issue:6 Volume:6 Page:415-416
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Pinto-Sietsma Sara-Joan¹,Flossdorf Michael²,Buchholz Veit R²,Offerhaus Joost¹,Bleijendaal Hidde¹,Beudel Martijn¹,Volders Paul G A³^ORCID,ter Bekke Rachel M A³,Dormans Tom⁴,Zwetsloot Peter-Paul⁵,de Jager Peter⁵,Massberg Steffen⁶,Rämer Patrick⁷,Wendtner Clemens⁷,Hoffmann Ellen⁸,Rothe Kathrin²,Feihl Susanne⁹,Kessler Thorsten¹⁰,Pinto Yigal M¹^ORCID,Schunkert Heribert¹⁰

Affiliation:

1. University of Amsterdam, Amsterdam, The Netherlands

2. Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Deutsches Zentrum für Infektionsforschung, München, Germany

3. Maastricht University, Maastricht, The Netherlands

4. Zuyderland Hospital, Heerlen, The Netherlands

5. Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands

6. Department of Cardiology. Klinikum der Ludwig-Maximilians-Universität and Deutsches Zentrum für Herz-Kreislauf-Forschung, München, Germany

7. Department of Hospital Hygiene and infection prevention, Munich Municipal Hospital Group, München, Germany

8. Department of Cardiology and Internal Intensive Care Medicine, Heart Center Munich-Bogenhausen, Munich Municipal Hospital Group, Englschalkinger Str. 77, Munich, Germany

9. Klinikum Rechts der Isar, Technische Universität München, München, Germany

10. Department of Cardiology, Technische Universität München, Deutsches Zentrum für Herz-Kreislauf-Forschung, Munich Heart Alliance; München, Germany

Funder

Netherlands Heart Foundation CVON-PRIME

German Federal Ministry of Education and Research

BMBF

Cardiovascular Disease

Munich Heart Alliance

British Heart Foundation

German Centre of Cardiovascular Research

DZHK

German Research Foundation